Ethical Dilemma with Stakeholders
You're the CEO of a pharmaceutical company. Your best-selling drug ($2B annual revenue, used by 4 million patients for chronic pain) has…
As CEO, my primary obligation is to the patients. While a 40% stock drop is a financial catastrophe, a cover-up that leads to preventable deaths is a corporate death sentence and a moral failure. If we "wait for more data" and another patient dies during that window, we move from "negligence" to "criminal intent."Read the full answer
You are facing a test that will define you, the company, and potentially your freedom. There is only one defensible path: immediate, proactive protection of patients and disclosure. Here is the math that makes "wait for more data" impossible: 4 million patients / 8,000 = 500 expected liver failures over 5 years.Read the full answer